Active Ingredient History
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and corticosteroids. Pegaspargase can be administered either via an intravenous infusion or a intramuscular injection. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Down Syndrome (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Hematologic Neoplasms (Phase 4)
Hodgkin Disease (Phase 2)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphoid (Phase 1)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, T-Cell (Phase 2/Phase 3)
Lymphohistiocytosis, Hemophagocytic (Phase 4)
Lymphoma (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 3)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 4)
Medulloblastoma (Phase 4)
Mucositis (Phase 3)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 4)
Ovarian Neoplasms (Phase 2)
Pediatrics (Phase 1)
Peritoneal Neoplasms (Phase 2)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Testicular Neoplasms (Phase 3)
Treatment Refusal (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
